Lv31
384 积分 2023-05-27 加入
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
1个月前
已完结
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
1个月前
已完结
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression
2个月前
已完结
Bulevirtide for chronic hepatitis delta: from clinical trials to real life data: an expert opinion report
5个月前
已关闭
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
7个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
8个月前
已完结
Bile acid metabolism in health and ageing-related diseases
8个月前
已完结
Comparative Efficacy of Treatment Regimens for Chronic Hepatitis D Virus Infection: A Systematic Review and Network Meta-Analysis
9个月前
已完结
The worldwide medical impact of hepatitis D virus infection: Focus to Central Asia
9个月前
已完结
Update on the management of HDV infection: current events and perspectives
9个月前
已完结
皖公网安备34019202002308
